← Back to Search

Behavioral Intervention for Breast Cancer

N/A
Waitlist Available
Led By Susan Eggly, PhD
Research Sponsored by Barbara Ann Karmanos Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (time 1) to pre-clinic visit (time 2) post-clinic visit (time 3)
Awards & highlights

Study Summary

This trial is testing a way to improve communication between patients and their cancer doctors, by giving patients a brochure with questions to ask their doctor.

Eligible Conditions
  • Breast Cancer
  • Bladder Cancer
  • Ovarian Cancer
  • Prostate Cancer
  • Cervical Cancer
  • Kidney Cancer
  • Lung Cancer
  • Colorectal Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (time 1) to pre-clinic visit (time 2) post-clinic visit (time 3)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (time 1) to pre-clinic visit (time 2) post-clinic visit (time 3) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Self-efficacy in managing patient-physician interactions
Secondary outcome measures
Change in distress
Change in knowledge related to the patient's cancer and treatment
Change in trust in physicians
+1 more

Side effects data

From 2013 Phase 1 & 2 trial • 16 Patients • NCT01923896
13%
Diarrhea
100%
80%
60%
40%
20%
0%
Study treatment Arm
Behavioral Intervention & DCS
Behavioral Intervention & Placebo

Trial Design

1Treatment groups
Experimental Treatment
Group I: Health services research (ASQ brochure)Experimental Treatment1 Intervention
Patients receive ASQ brochure and complete questionnaires over 30 minutes at baseline, over 10 minutes pre-clinic visit, and over 30 minutes post-clinic visit.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Behavioral Intervention
2021
Completed Phase 4
~3740

Find a Location

Who is running the clinical trial?

Barbara Ann Karmanos Cancer InstituteLead Sponsor
163 Previous Clinical Trials
9,175 Total Patients Enrolled
18 Trials studying Breast Cancer
1,223 Patients Enrolled for Breast Cancer
Susan Eggly, PhDPrincipal InvestigatorWayne State University
~22 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top